Strides Pharma Science informs about press release

18 Dec 2020 Evaluate
Strides Pharma Science has informed that it has enclosed press release titled, ‘Strides receives USFDA approval for Oxybutynin Chloride Tablets’.

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

878.65 -7.00 (-0.79%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×